(Q44446057)

English

The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators

scientific article published in April 2003

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

3 December 2017

The prognostic impact of hormone receptors and c-erbB-2 in pregnancy-associated breast cancer and their correlation with BRCA1 and cell cycle modulators (English)

1 reference

Europe PubMed Central

3 December 2017

Jahn M. Nesland

4

object named as

Jahn M Nesland

1 reference

Europe PubMed Central

3 December 2017

author name string

Wenche Reed

1

1 reference

Europe PubMed Central

3 December 2017

Berit Sandstad

2

1 reference

Europe PubMed Central

3 December 2017

Ruth Holm

3

1 reference

Europe PubMed Central

3 December 2017

publication date

1 April 2003

1 reference

Europe PubMed Central

3 December 2017

International Journal of Surgical Pathology

1 reference

Europe PubMed Central

3 December 2017

11

1 reference

Europe PubMed Central

3 December 2017

2

1 reference

Europe PubMed Central

3 December 2017

65-74

1 reference

Europe PubMed Central

3 December 2017

Gestational carcinoma of the female breast

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Overall survival from breast cancer in women pregnant or lactating at or after diagnosis. Auckland Breast Cancer Study Group

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Early-onset breast cancer--histopathological and prognostic considerations

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Survival of breast cancer patients diagnosed during pregnancy or lactation

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

BRCA1 mutations in primary breast and ovarian carcinomas.

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Aberrant subcellular localization of BRCA1 in breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Cyclin E overexpression, a negative prognostic factor in breast cancer with strong correlation to oestrogen receptor status

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

A specific role for cyclin D1 in mammary gland development

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Method for grading breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

The subcellular localization of the neu protein in human normal and neoplastic cells

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Rat monoclonal antibodies to the external domain of the product of the C-erbB-2 proto-oncogene

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Clinicopathologic characteristics and prognosis of breast cancer patients associated with pregnancy and lactation: analysis of case-control study in Japan

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

The nuclear localization sequences of the BRCA1 protein interact with the importin-alpha subunit of the nuclear transport signal receptor

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation.

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

BRCA1 Mutations and Breast Cancer in the General Population

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Decreased levels of the cell-cycle inhibitor p27Kip1 protein: prognostic implications in primary breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Down-regulation of p21WAF1/CIP1 or p27Kip1 abrogates antiestrogen-mediated cell cycle arrest in human breast cancer cells

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Cyclin D1 and prognosis in human breast cancer

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Overexpression of cyclinD1 predicts for poor prognosis in estrogen receptor-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Effects of oncogenic ErbB2 on G1 cell cycle regulators in breast tumour cells

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

ErbB-2-induced mammary tumor growth: the role of cyclin D1 and p27Kip1.

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Specific protection against breast cancers by cyclin D1 ablation

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Suppression of Neu-induced mammary tumor growth in cyclin D1 deficient mice is compensated for by cyclin E.

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Cyclin D1 is required for transformation by activated Neu and is induced through an E2F-dependent signaling pathway

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: immunohistochemical analysis and clinicopathologic correlation

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

BRCA1Mutations in a Population-Based Sample of Young Women with Breast Cancer

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Rescue of Cyclin D1 Deficiency by Knockin Cyclin E

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Pregnancy and risk of early breast cancer in carriers of BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1177%2F106689690301100201

21 January 2018

Identifiers

10.1177/106689690301100201

1 reference

Europe PubMed Central

3 December 2017

1 reference

Europe PubMed Central

3 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44446057&oldid=2024445048"